Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A pivotal phase IIb/III trial of WT1 vaccine in patients with malignant pleural mesothelioma

Trial Profile

A pivotal phase IIb/III trial of WT1 vaccine in patients with malignant pleural mesothelioma

Status: Planning
Phase of Trial: Phase II/III

Latest Information Update: 25 Sep 2016

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Galinpepimut S (Primary)
  • Indications Malignant-mesothelioma
  • Focus Registrational; Therapeutic Use
  • Sponsors Sellas Life Sciences Group
  • Most Recent Events

    • 14 Sep 2016 According to Sellas Life Sciences Group media release, this trial is expected to start in early 2017.
    • 14 Sep 2016 Planned initiation date changed from 1 Jul 2016 to 1 Jan 2017, as per Sellas Life Sciences Group media release.
    • 29 Mar 2016 According to SELLAS Life Sciences media release, based on results of phase II trial (see CTP 700192768), the company plans to initiate this pivotal trial of WT1 peptide vaccine in patients with MPM, in the third quarter of 2016.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top